RecruitingNCT03327779
World Bleeding Disorders Registry
Sponsor
World Federation of Hemophilia
Enrollment
20,000 participants
Start Date
Jan 26, 2018
Study Type
OBSERVATIONAL
Conditions
Summary
The WBDR is an international observational disease registry of patients with hemophilia. It will provide a platform for a network of hemophilia treatment centres (HTCs) around the world to collect uniform and standardized patient data and guide clinical practice. With informed consent from the patient, the WBDR stores anonymous data about the person's disease, such as hemophilia type and severity, symptoms, and treatment.
Eligibility
Inclusion Criteria1
- Patients of participating Hemophilia Treatment Centres with Hemophilia A or B, or von Willebrand Disease
Exclusion Criteria1
- none
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03327779
Related Trials
Development of a Device for Evaluating Primary Hemostasis Under Whole Blood Flow Conditions
NCT037731592 locations
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
NCT070809059 locations
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
NCT0556871916 locations
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
NCT0561180166 locations
Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog Alfa
NCT0694083027 locations